首页> 外文期刊>Hypertension: An Official Journal of the American Heart Association >Dissociation between sympathetic nerve traffic and sympathetically mediated vascular tone in normotensive human obesity.
【24h】

Dissociation between sympathetic nerve traffic and sympathetically mediated vascular tone in normotensive human obesity.

机译:正常人肥胖症中交感神经交通与交感神经介导的血管紧张度之间的分离。

获取原文
获取原文并翻译 | 示例
           

摘要

Obesity increases the risk of hypertension and its cardiovascular complications. This has been partly attributed to increased sympathetic nerve activity, as assessed by microneurography and catecholamine assays. However, increased vasoconstriction in response to obesity-induced sympathoactivation has not been unequivocally demonstrated in obese subjects without hypertension. We evaluated sympathetic alpha-adrenergic vascular tone in the forearm by brachial arterial infusion of the alpha-adrenoreceptor antagonist phentolamine (120 microg/min) in normotensive obese (daytime ambulatory arterial pressure: 123+/-1/77+/-1 mm Hg; body mass index: 35+/-1 kg/m(2)) and lean (daytime ambulatory arterial pressure: 123+/-2/77+/-2 mm Hg; body mass index: 22+/-1 kg/m(2)) subjects (n=25 per group) matched by blood pressure, age, and gender. Microneurographic sympathetic nerve activity to skeletal muscle was significantly higher in obese subjects (30+/-3 versus 22+/-1 bursts per minute; P=0.02). Surprisingly, complete alpha-adrenergic receptor blockade by phentolamine (at concentrations sufficient to completely inhibit norepinephrine and phenylephrine-induced vasoconstriction) caused equivalent vasodilatation in obese (-57+/-2%) and lean subjects (-57+/-3%; P=0.9). In conclusion, sympathetic vascular tone in the forearm circulation is not increased in obese normotensive subjects despite increased sympathetic outflow. Vasodilator factors or mechanisms occurring in obese normotensive subjects could oppose the vasoconstrictor actions of increased sympathoactivation. Our findings may help to explain why some obese subjects are protected from the development of hypertension.
机译:肥胖会增加患高血压及其心血管并发症的风险。如通过微神经造影术和儿茶酚胺测定所评估的,这部分归因于交感神经活动的增加。然而,在没有高血压的肥胖受试者中,没有明确证明对肥胖引起的交感神经激活的血管收缩作用增加。我们通过在血压正常的肥胖(白天非卧床动脉压:123 +/- 1/77 +/- 1 mm Hg)中通过肱动脉输注α-肾上腺素能受体拮抗剂苯妥拉明(120微克/分钟)来评估前臂中的交感性α-肾上腺素血管张力。 ;体重指数:35 +/- 1 kg / m(2))和瘦肉(白天门诊动脉压:123 +/- 2/77 +/- 2 mm Hg;体重指数:22 +/- 1 kg / m(2))受试者(每组n = 25)与血压,年龄和性别相匹配。在肥胖受试者中,对骨骼肌的微神经交感神经活动显着更高(每分钟30爆发3次与22 +/- 1次爆发; P = 0.02)。出人意料的是,苯妥拉明(浓度足以完全抑制去甲肾上腺素和去氧肾上腺素引起的血管收缩)完全阻断α-肾上腺素能受体,在肥胖(-57 +/- 2%)和瘦的受试者(-57 +/- 3%)中引起等效的血管舒张。 P = 0.9)。总之,肥胖的血压正常者的前臂循环中的交感性血管张力没有增加,尽管交感性流出增加了。肥胖的血压正常个体中发生的血管舒张因子或机制可能与交感神经激活增加的血管收缩作用相反。我们的发现可能有助于解释为什么某些肥胖受试者可以免受高血压的困扰。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号